2016
Parvovirus B19
Landry ML. Parvovirus B19. Microbiology Spectrum 2016, 4: 10.1128/microbiolspec.dmih2-0008-2015. PMID: 27337440, DOI: 10.1128/microbiolspec.dmih2-0008-2015.Peer-Reviewed Original ResearchConceptsParvovirus B19 infectionIntravenous immunoglobulinB19 infectionIgG antibodiesImmune systemActive parvovirus B19 infectionPrimary parvovirus B19 infectionPure red cell aplasiaMaintenance intravenous immunoglobulinRed cell transfusionSufficient immune responsePatient's immune systemRed cell aplasiaReal-time polymerase chain reaction methodRed cell precursorsB19 variantsGiant pronormoblastsRecurrent anemiaB19 IgMChronic anemiaPolymerase chain reaction methodSevere anemiaTherapeutic optionsPrimary infectionParvovirus B19
2007
Serum IgA Antibodies to Epstein-Barr Virus (EBV) Early Lytic Antigens Are Present in Primary EBV Infection
Bhaduri-McIntosh S, Landry ML, Nikiforow S, Rotenberg M, El-Guindy A, Miller G. Serum IgA Antibodies to Epstein-Barr Virus (EBV) Early Lytic Antigens Are Present in Primary EBV Infection. The Journal Of Infectious Diseases 2007, 195: 483-492. PMID: 17230407, DOI: 10.1086/510916.Peer-Reviewed Original ResearchConceptsPrimary EBV infectionSerum IgA antibodiesIgA antibodiesEBV infectionLytic antigensPrimary infectionPrimary Epstein-Barr virus infectionHealthy EBV-seropositive individualsEpstein-Barr virus infectionEB nuclear antigenEBV-seropositive individualsViral capsid antigenAbsence of antibodiesFlow cytometry-based assayLytic EBV replicationCytometry-based assayBurkitt's lymphoma cellsCapsid antigenMucosal sitesEBV replicationIgM antibodiesVirus infectionInfectionLymphoma cellsSerum samples